Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke
(0) - Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone. *,¹ CARDIOFORM Septal Occluder can be trusted for patient safety and effective defect closure. FLAGSTAFF, Ariz., March 11, 2021 /PRNewswire/ -- W. L. Gore & Associates (Gore), today announced that Gore REDUCE Study long-term follow-up results were published in the March 2021 issue of The New England Journal of Medicine (NEJM), highlighting the benefits of patent foramen ovale (PFO) closure. ...